Search for: "Biogen, Inc. v. Amgen Inc."
Results 1 - 20
of 24
Sorted by Relevance
|
Sort by Date
18 Dec 2019, 9:59 pm
For example, in Classen Immunotherapies, Inc. v. [read post]
17 Mar 2022, 2:32 pm
See Amgen Inc. v. [read post]
29 Apr 2021, 6:39 am
Amgen v. [read post]
1 Jul 2022, 10:02 am
The current most-likely big case is Amgen Inc., et al. v. [read post]
28 Sep 2020, 8:00 am
by Dennis Crouch Biogen MA, Inc. v. [read post]
1 Nov 2019, 6:02 am
Biogen insufficiency: Enablement over the entire scope of the claimLord Hoffman established in Biogen Inc v Medeva plc [1997] RPC 1, that a specification must enable the invention to be performed across the full scope of the claim. [read post]
6 Oct 2020, 7:55 am
The decision came in Biogen MA Inc. v. [read post]
4 Mar 2016, 12:25 pm
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Preclusion or Jurisdiction: Biogen MA, Inc. v. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences… [read post]
18 Apr 2016, 9:58 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 Jun 2016, 6:40 am
Jack Henry & Associates, Inc., No. 15-974 (defining an abstract idea) Biogen MA, Inc. v. [read post]
26 Sep 2022, 4:49 am
Full Scope Enablement in Amgen Inc. v. [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 May 2016, 1:42 am
Jack Henry & Associates, Inc., No. 15-974 (defining an abstract idea) Biogen MA, Inc. v. [read post]
17 Mar 2016, 2:45 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Preclusion or Jurisdiction: Biogen MA, Inc. v. [read post]
28 Jun 2016, 6:41 am
Amgen (BPCIA patent dance). [read post]
7 Feb 2019, 12:08 pm
Amgen, Inc. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
23 Oct 2008, 10:31 am
" Meanwhile, "Rituxan (rituximab), which Genentech sells with Biogen-Idec Inc. for lymphoma, caused rare cases of...progressive multifocal leukoencephalopathy (PML)," a condition that "is also tied to Biogen's multiple sclerosis drug Tysabri (natalizumab). [read post]
